Dott. Filomena Fezza
Adjunct professor
Biography
Associate Professor at the Department of Experimental Medicine, University of Rome "Tor Vergata"; his research is carried out at the Department of Experimental Medicine of the University of Rome "Tor Vergata" and the Biochemistry Laboratory of the Campus Bio-Medico; 09/2006-09/2013 also at the European Center for Brain Research (CERC)/IRCCS S. Lucia Foundation; in particular: i) involvement of the endocannabinoid system in neurodegenerative diseases; ii) synthesis of new probes for the study of endocannabinoid transport; ii) identification of new synthetic inhibitors of the enzyme responsible for the hydrolysis of the endocannabinoid anandamide; iv) involvement of lipid rafts in endocannabinoid signaling; v) Computational approach to the study of cannabinoid receptor signaling.
E-MAIL: [email protected]
Curriculum
Studies and Qualifications
Professor of "Chemistry and Biochemistry" (7 credits), Medicine and Surgery Degree; Campus Bio-Medico University of Rome.
Studies and Qualifications
2020-present Professor of "Biochemistry", SCHOOL OF SPECIALIZATION IN CLINICAL PATHOLOGY AND CLINICAL BIOCHEMISTRY, Degree course in Medicine and Surgery, University of Rome "Tor Vergata"
2015-2021 Lecturer in "Stoichiometry" (1 credit, 8 hours; CHIM/03), Degree Program in Biomedical Laboratory Diagnostic Techniques. University of Rome "Tor Vergata"
2014-present Professor of “Biochemistry”, Integrated Course in Anatomy and Biochemistry, Master's Degree in Sports Sciences and Techniques (5 total credits) and Master's Degree in Sports Sciences and Techniques (5 total credits), University of Rome “TorVergata”
2013-present Professor of “Chemistry and biochemical propaedeutics” (2 CFU), International College of Osteopathic Manual Medicine of Rome
2009-present Lecturer of the course “Chemistry and Biochemistry Propaedeutics” (7 CFU), Degree Course in Medicine and Surgery; "Campus Bio-Medico" University of Rome.
2009-present: Member of the Teaching Board of the PhD program in Biochemistry and Molecular Biology, University of Rome "Tor Vergata"
2021-2023 Professor of "Biochemistry" (5 credits), Degree in Medicine and Surgery; Campus Bio-Medico University of Rome.
2006-2015 Co-teacher of the course "Chemistry and Biochemical Propaedeutics" (2 total credits), Degree Course in Biomedical Laboratory Diagnostic Techniques; University of Rome "Tor Vergata"
2014/2015 Professor of “Biochemistry”, Biochemistry Course, Degree in Pharmacy (5 CFU), University of Rome “TorVergata”
2008-2011 Member of the Teaching Staff of the PhD program in "Biochemical Sciences and Technologies Applied to Food and Nutrition", Campus Bio-Medico University of Rome.
2005/2008 Supplementary teaching for the integrated course of “Biochemistry and Human Genetics” (1 CFU), Degree for Orthopedic Technicians, University of Rome “TorVergata”
11/2003-10/2006 PhD in BIOCHEMISTRY AND MOLECULAR BIOLOGY, University of Rome "Tor Vergata"; Supervisor: Prof. A. Finazzi-Agrò
10/2000 Qualification to practice as a chemist
October 1993-February 2000: Degree in Chemistry, University of Salerno; Supervisors: Prof. G. Sodano and Prof. F. De Riccardis.
ADDITIONAL PROFESSIONAL TITLES
National Scientific Qualification Competition Sector 05/E1 - II Band - 2016
National Scientific Qualification Competition Sector 05/E1 - II Band - 2012
Work experiences
10/2006 to present Confirmed Researcher at the Faculty of MEDICINE AND SURGERY of the University of Rome "Tor Vergata"
11/2003-10/2006 PhD at the Department of Experimental Medicine and Biochemical Sciences of the University of Rome “Tor Vergata”
04/2003-10/2003 Research grant with the University of Teramo under the supervision of Prof. M. Maccarrone as part of the project “Endocannabinoids and maternal-fetal recognition”
03/2000-03/2003 Collaboration contract with the Institute of Biomolecular Chemistry of the National Research Council (ICB-CNR) based in Pozzuoli (NA) under the supervision of Dr. V. Di Marzo funded by the company Research & Innovation and having as its research object “Immunoinflammatory and degenerative diseases of the nervous system: pathophysiological aspects and diagnostic and therapeutic development”
02/2000-03/2000 Scholarship with the pharmaceutical company Asta Medica at the Department of Chemistry of the University of Salerno for the synthesis of the natural substance (E)- and (Z)-volkendousin
PUBLICATIONS
Published 81 articles in international refereed journals (68 original papers, 9 review articles, 4 book chapters); h-index = 44; citations = 8580 (source: Scopus).
• Gagestein B.,et al. Chemical proteomics reveals off-targets of the anandamide reuptake inhibitor WOBE437 (2022) ACS Chemical Biology in press (IF 5.100)
• Fezza, F., et al. Assay of NAPE-PLD activity (2022) Methods Mol Biol. 2022 in press (IF 1.17).
• Grillo A, Fezza F, et al. Selective Fatty Acid Amide Hydrolase Inhibitors as Potential Novel Antiepileptic Agents. ACS Chem Neurosci. (2021) May 5;12(9):1716-1736 • Criscuolo E, et al. In Silico and In Vitro Analysis of Major Cannabis-Derived Compounds as Fatty Acid Amide Hydrolase Inhibitors. Molecules. (2020) Dec 24;26(1):48
• Rossi G, et al. Bisphenol A Deranges the Endocannabinoid System of Primary Sertoli Cells with an Impact on Inhibin B Production. Int J Mol Sci. (2020) Nov 26;21(23):8986
• Greco L, et al. Characterization of Endocannabinoid System and Interleukin Profiles in Ovine AEC: Cannabinoid Receptors Type-1 and Type-2 as Key Effectors of Pro-Inflammatory Response. Cells. (2020) Apr 18;9(4):1008
• Fazio D, et al. Advances in the discovery of fatty acid amide hydrolase inhibitors: what does the future hold? Expert Opin Drug Discov. (2020) Jul;15(7):765-778
• Dainese E, et al. The endocannabinoid hydrolase FAAH is an allosteric enzyme. Sci Rep. (2020) Feb 10;10(1):2292
• Grillo A, et al. Development of novel multipotent compounds modulating endocannabinoid and dopaminergic systems. Eur J Med Chem. (2019) Dec 1;183:111674